Markus Axelsson

11PUBLICATIONS
29CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesMedical molecular engineering of nucleic acids and proteinsCentral nervous systemMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 24, 2023
Paraneoplastic or not? Sirtuin 2 in anti-N-methyl-d-aspartate receptor encephalitis.

Oskar Stevens-Jones, Hana Mojzisova, Martin Elisak

|Jul 19, 2021
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy.

Kalle Johansson, Pontus Wasling, Markus Axelsson

|Mar 04, 2021
The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis.

Simone Hjæresen, Tobias Sejbaek, Marcus Axelsson

|May 28, 2020
Inflammation-related plasma and CSF biomarkers for multiple sclerosis.

Jesse Huang, Mohsen Khademi, Lars Fugger

|May 17, 2020
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.

Daniel Jons, Henrik Zetterberg, Clas Malmeström

|Oct 08, 2019
Neuronal antibodies in adult patients with new-onset seizures: A prospective study.

Johan Zelano, Markus Axelsson, Radu Constantinescu

Pageof 2